Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 372 followers
Latest posts
Last updated about 3 hours ago
J&J, Legend crunch the multiple myeloma numbers in 1st Carvykti TV ad
about 3 hours ago
The first commercial for Johnson & Johnson and Legend Biotech’s Carvykti focuses...
Celltrion closes in on US plant purchase, dubbing local drug substance facility 'fundamental' to tariff mitigation
about 3 hours ago
As Celltrion looks to ward off potential import tariffs, the South Korean...
FDA taps newly appointed George Tidmarsh as acting CBER leader after Prasad exit
about 5 hours ago
Following the departure of Vinay Prasad, M.D., former head of the Center...
Guardant taps James Van Der Beek to promote colon cancer screening blood test
about 6 hours ago
With rates of colorectal cancer surging among younger populations, Guardant Health is...
Despite Blenrep uncertainty, GSK sticks to its £40B sales projection for 2031
about 7 hours ago
With a portfolio of 14 potential blockbuster treatments that it expects to...
Takeda wades through more Vyvanse declines, muses DTC model as US pricing uncertainty looms
about 7 hours ago
The Japanese drugmaker's quarterly revenues took an 8.4% hit with continued Vyvanse-related...
Teva execs shrug off pharmaceutical tariff threat as turnaround strategy rolls forward
about 7 hours ago
As more drugmakers begin to report second-quarter earnings against the backdrop of...
Vinay Prasad departs FDA amid conservative criticism, controversy over Sarepta gene therapy
about 8 hours ago
Controversies, including a recent regulatory tug-of-war with Sarepta and criticism from conservatives...
Daré starts push to arouse interest in women’s sexual health drug, tapping app for education drive
about 8 hours ago
Daré Bioscience has started a consumer awareness campaign to lay the foundations...
In BTK clash, Lilly upstart Jaypirca measures up to warhorse Imbruvica
1 day ago
In a phase 3 trial, the newest Bruton’s tyrosine kinase (BTK) inhibitor...
AZ proposes US price cut options as CEO Soriot sides with global ‘rebalancing of pricing’
1 day ago
AstraZeneca CEO Pascal Soriot said the company has had many talks with...
Publicis Health picks up p-value medical comms group
1 day ago
After a first half that saw Publicis Groupe snap up six companies...